Author:
Li Yan,Melnikov Anatoliy A.,Levenson Victor,Guerra Emanuela,Simeone Pasquale,Alberti Saverio,Deng Youping
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Reference107 articles.
1. Oncofem P. Carcinoma della mammella in Italia. Federazione Medica. 1992;9:11–6.
2. Group EBCTC. Polychemotherapy for early breast cancer: an overview of the randomised trials. Lancet. 1998;352:930–42.
3. Ambrogi F, Fornili M, Boracchi P, Trerotola M, Relli V, Simeone P, et al. Trop-2 is a determinant of breast cancer survival. PLoS One. 2014;9:e96993.
4. Biganzoli E, Coradini D, Ambrogi F, Garibaldi JM, Lisboa P, Soria D, et al. p53 status identifies two subgroups of triple-negative breast cancers with distinct biological features. Jpn J Clin Oncol. 2011;41:172–9.
5. Ambrogi F, Fornili M, Alberti S, Querzoli P, Piantelli M, Pedriali M, et al. EpCAM expression is an indicator of increased incidence of relapse in p53-positive breast cancer. Cancer Clin Oncol. 2013;2:41–50.
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献